Imbruvica Price (ibrutinib)

Imbruvica price by strength

Cheapest ways to get Imbruvica 140 mg capsule

The cheapest ways we found to get brand Imbruvica 140 mg capsule (prices checked Nov 5, 2026). The lowest 90-day cost is shaded green.

Costs abroad and at U.S. pharmacies are for one order closest to 90 days, shipping included, from the price table above. Programs set their own rules, so check the terms before you count on one.

How much does Imbruvica cost without insurance?

Without insurance, Imbruvica costs $10,620.08 for a 30-day supply at the U.S. list price, or about $31,860.24 for 90 days. Myabbvie assist: Free Imbruvica for people who qualify, including household income of $77,280 or less for one person or $159,000 or less for a family of 4. Call 1-800-222-6885 (AbbVie).

Imbruvica cost with Medicare

In 2026, a Medicare drug plan (Part D) can charge a deductible of up to $615, and once you've spent $2,100 out of pocket on covered drugs, you pay nothing more for covered drugs that year ($2,400 in 2027) (Medicare.gov). What you pay for Imbruvica depends on your plan's drug list and your coverage phase. Since January 1, 2026, Medicare pays a negotiated price of $9,319 for a 30-day supply of Imbruvica (CMS, checked 2026-10-29). That's what Medicare pays, not your copay. If your income is limited, Extra Help lowers drug costs: in 2026 you pay no more than $5.10 for a generic and $12.65 for a brand-name drug, with income under $23,940 ($32,460 for a married couple) and resources under $18,090 ($36,100 for a couple) (CMS). The free Medicare Prescription Payment Plan spreads costs into monthly payments, but it doesn't lower the total.

Imbruvica cost with insurance

With private or employer insurance, what you pay for Imbruvica depends on your plan's drug list, deductible and copay. As little as $0 per prescription with the IMBRUVICA copay program, up to $24,600 a year. Your copay otherwise depends on your plan (Imbruvica.com).

Medicaid: Your state Medicaid program sets any copay. Ask your pharmacist or state Medicaid office (Medicaid.gov).

Imbruvica patient assistance program

Pharmacyclics and Janssen runs myAbbVie Assist. Who qualifies: People in the U.S. with limited or no health insurance coverage who meet income limits: household income of $77,280 or less for 1 person, $104,520 for 2, $131,760 for 3 or $159,000 for 4 (add $27,240 for each extra person). People with insurance may also be reviewed based on their coverage. We couldn't confirm on the program's own pages that Imbruvica is on its current list (checked 2026-10-29), so call 1-800-222-6885 to ask before you apply.

Imbruvica FAQ

Savings programs from the maker

eDrugSearch does not offer its own Imbruvica coupons. We found no cash-price program for Imbruvica from AbbVie or Johnson & Johnson in our latest check. These are the programs we could verify:

• IMBRUVICA Copay Card: for people with commercial insurance that covers Imbruvica. Eligible patients may pay as little as $0 per prescription, up to $24,600 per calendar year. Not for Medicare (including Part D), Medicare Advantage, Medigap, Medicaid, TRICARE, DoD, VA or other government programs, and some states are excluded. Monthly maximums may apply. Call 1-888-968-7743. (IMBRUVICA Copay Card)
• myAbbVie Assist (patient assistance): AbbVie's patient assistance program provides AbbVie medicine at no cost to qualifying U.S. residents with limited or no health insurance who meet household income limits. People with private insurance or Medicare may also apply; AbbVie looks at their coverage, income and out-of-pocket costs. If you have Medicare Part D and income below 150% of the federal poverty level, you must first apply for Extra Help. Call 1-800-222-6885. (myAbbVie Assist income criteria)
• IMBRUVICA By Your Side: the makers' support program. For people with Medicare, Medicaid or no insurance, its insurance specialists help look for other support; the makers say help may be available through an independent foundation. Call 1-888-968-7743 (Monday to Friday, 8 a.m. to 8 p.m. ET). (Affording Imbruvica)
• Medicare Extra Help: if you have Medicare and limited income, Extra Help lowers what you pay for prescriptions. (Social Security)
• Medicare Prescription Payment Plan: a free Medicare option that spreads your drug costs into monthly payments across the year. It doesn't lower the total, but it can make costs easier to manage. Imbruvica's makers say people getting foundation or charity help should not enroll. (Medicare.gov)

Compare Imbruvica with similar drugs

Jakafi (ruxolitinib) is another kinase inhibitor FDA-approved for chronic graft-versus-host disease. Other BTK inhibitors for CLL, such as Calquence (acalabrutinib) and Brukinsa (zanubrutinib), don't have price pages here yet.

Lowest 90-day price including shipping, from licensed pharmacies shipping to the U.S., any strength. Only your doctor can decide whether another drug is right for you.

What is Imbruvica used for?

Imbruvica (ibrutinib) is a kinase inhibitor (a BTK inhibitor). According to its FDA label (DailyMed), it is used:

• In adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), including CLL or SLL with 17p deletion.
• In adults with Waldenström's macroglobulinemia.
• In adults and children 1 year and older with chronic graft-versus-host disease (cGVHD) after one or more other systemic treatments did not work.

Imbruvica comes as 140, 280 and 420 mg tablets (28 per pack), 70 mg capsules (bottles of 28) and 140 mg capsules (bottles of 90 or 120), plus an oral suspension (70 mg/mL). The label dose for adults is 420 mg once a day; children with cGVHD are dosed by body size. Imbruvica has no boxed warning; the label warns about bleeding, infections, heart rhythm problems and heart failure, high blood pressure, low blood counts, new cancers, liver injury, tumor lysis syndrome and harm to an unborn baby. The makers list a network of specialty pharmacies authorized to dispense Imbruvica (list). In the U.S., its mantle cell and marginal zone lymphoma uses were withdrawn in 2023, though they remain approved in other countries. Your prescriber decides which medicine is right for you.